Laserfiche WebLink
BSKANALYTICAL <br /> LABORATORIES <br /> QC Summary Report 10/01/2002 1111111111111111111111HE1111111111111111111111111 <br /> 111111111111111111111111111111111 <br /> BSK Subrrussion 2002090292 <br /> Client Caltest Analytical Laboratory <br /> Date Submitted 09/06/2002 <br /> Protect ID C090158 <br /> Protect Desc <br /> BSK StarLtms Run # 43037 1 Bill fill lop 11111119111111111111 Instrument ID GC7 <br /> Analyst Initials RACHELM Method Number 5153 <br /> Analyte Results Matrix %Rec Spike Spk Matrix <br /> Analyte QC Type Spike ID Result Units or RPD RPD Cone Conc UCL LCL Date <br /> 2,4,5-TP(Silvex) RBLK <br /> N/A 0 11g2 <1 1 N/A 09/10/02 Acceptable <br /> 2,4-D RBLK NIA 0 µg/L < 10 10 N/A 09/10/02 Acceptable <br /> Bentazon(Basagran) RBLK N/A 0 µg/L <2 2 N/A 09/10/02 Acceptable <br /> Dalapon RBLK N/A 0 µg/L <10 10 N/A 09/10/02 Acceptable <br /> Dicamba(Banvel) RBLK N/A 0 µg/L <15 1 5 NIA 09/10/02 Acceptable <br /> Dinoseb(DNBP) RBLK N/A 0 µglL <2 2 N/A 09/10/02 Acceptable <br /> Pentachlorophenol(PCP) RBLK N/A 0 µg/L <02 0 2 N/A 09/10/02 Acceptable <br /> Picloram RBLK N/A 0 µg/L <1 1 N/A 09/10/02 Acceptable <br /> Surrogate Results <br /> Analyte QC Type Surr Result UCL LCL Date <br /> . DCPAA LCS N/A 84 %Rec 86 130 70 09/10/02 Acceptable <br /> DCPAA LCSD N/A 81 %Rec 86 130 70 09/10/02 Acceptable <br /> DCPAA MS 243873 81 %Rec 86 130 70 09/10/02 Acceptable <br /> DCPAA ——————— MSD — 243873 79 %Rec 86 130 70 09/10/02 Acceptable <br /> --- r — — ----�w----.___— <br /> DCPAA RBLK N/A 0 %Rec 4— 130 70 09/10/02 Acceptable <br /> BSK StarLims Run # 43156 111110 pill 111oll111111ll101IN Instrument ID GC9 <br /> Analyst Inatials. JENNIFERD Method Number 5041 <br /> Analyte Results Matrix %Rec Spike Spk Matrix <br /> Analyte QC Type Spike ID Result Units or RPD RPD Cone Cone UCL LCL Date <br /> Dibromochloropropane LCS N/A 02354 µg/L. 94 25 ND 140 60 09/14/02 Acceptable <br /> Ethylenedibromide LCS N/A 02034 µg/L 81 25 ND 140 60 09/14/02 Acceptable <br /> Dibromochloropropane LCSD N/A 02154 µg/L 86 89 25 ND 140 60 09/14/02 Acceptable <br /> Ethylenedibromtde LCSD N/A 02074 µg/L 82 2 25 ND 140 60 09/14/02 Acceptable <br /> Dibromochloropropane MS 245543 08405 µg/L 110 25 051 140 60 09/14/02 Acceptable <br /> Ethylenedibromtde ———— MS 245543 02035 µg/L 81 25 ND 140 60 09/14/02 Acceptable <br /> Dtbromochloropropane RBLK NIA 0— µg/L — <001— — w 001 N/A 09/14/02 Acceptable <br /> Ethylenedibromtde RBLK N/A 0 µg/L <0 02 002 NIA 09/14/02 Acceptable <br /> Surrogate Results <br /> Analyte QC Type Surr Result UCL LCL Date <br /> Bromoform LCS N/A 104 5 %Rec 1116 140 60 09/14/02 Acceptable <br /> Bromoform LCSD N/A 105 5 %Rec 1116 140 60 09/14/02 Acceptable <br /> Bromoform MS 245543 109 %Rec 1133 I40 60 09/14/02 Acceptable <br /> %Rec Percent Recovered Parent Sample Sample used as background matrix for MS/MSD page 2 of 6 <br /> RPD Relative Percent Difference OOS-High QC Result Above UCL <br /> UCL Upper Control Limit OOS-Low QC Result Below LCL <br /> LCL Lower Control Limit <br />